Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Background. Atrial fibrillation (AF) is the most common serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality in general population. Hypertension is the most prevalent and potentially modifiable risk factor for AF. This study is aimed at evaluating the effect...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Haotian Ma, Hongcheng Jiang, Jing Feng, Yong Gan
Natura:	Articolo
Lingua:	English
Pubblicazione:	Hindawi-Wiley 2021-01-01
Serie:	Cardiovascular Therapeutics
Accesso online:	http://dx.doi.org/10.1155/2021/6628469

Documenti analoghi

Angiotensin&nbsp;II receptor blockers in the prevention of complications from atrial fibrillation
di: Gerald V Naccarelli, et al.
Pubblicazione: (2009-09-01)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
di: Cesare Cuspidi, et al.
Pubblicazione: (2008-02-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
di: Ji-Guang Wang
Pubblicazione: (2009-07-01)

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
di: Jun Kishihara, et al.
Pubblicazione: (2012-02-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
di: E. V. Kokhan, et al.
Pubblicazione: (2021-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
di: O. M. Drapkina, et al.
Pubblicazione: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
di: O. M. Drapkina, et al.
Pubblicazione: (2014-07-01)

Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
di: Weiss Michael J, et al.
Pubblicazione: (2010-02-01)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
di: Gorav Batra, et al.
Pubblicazione: (2017-03-01)

Termination of Aconitine-Induced Atrial Fibrillation by the KACh-Channel Blocker Tertiapin: Underlying Electrophysiological Mechanism
di: Kazumasa Suzuki, et al.
Pubblicazione: (2014-01-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
di: Nicole Habel, et al.
Pubblicazione: (2023-06-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
di: Antonio Eduardo Pesaro, et al.
Pubblicazione: (2010-01-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
di: Eiichiro Yamamoto, et al.
Pubblicazione: (2012-01-01)

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
di: Tadafumi Nanbu, et al.
Pubblicazione: (2023-06-01)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
di: Hyun Woong Lee
Pubblicazione: (2014-12-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
Pubblicazione: (2013-01-01)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
di: Nishida Yayoi, et al.
Pubblicazione: (2012-05-01)

The haemodynamic changes associated with treatment of new-onset atrial fibrillation with amiodarone or beta blockers
di: Bedford, J, et al.
Pubblicazione: (2021)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
di: Yanhua Yang, et al.
Pubblicazione: (2020-01-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
di: Athanasios Kartalis, et al.
Pubblicazione: (2024-06-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
di: Mohamed Zeinah, et al.
Pubblicazione: (2016-06-01)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
di: Hebah Hassan, BS, et al.
Pubblicazione: (2020-06-01)

The use of angiotensin receptor blockers in dementia prevention
di: Jordana de Araujo Müller, et al.
Pubblicazione: (2023-09-01)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
di: Tianyu Zhu, et al.
Pubblicazione: (2022-12-01)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis
di: Kotecha, D, et al.
Pubblicazione: (2014)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
di: Kotecha, D, et al.
Pubblicazione: (2014)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
di: Akif Arslan, et al.
Pubblicazione: (2016-01-01)

Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
di: Mina Mohammed, et al.
Pubblicazione: (2024-06-01)

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
di: Yen-Chung Lin, et al.
Pubblicazione: (2017-01-01)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
di: O. V. Dralova, et al.
Pubblicazione: (2016-01-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
di: O. D. Ostroumova, et al.
Pubblicazione: (2016-12-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
di: Tianyu Xu, et al.
Pubblicazione: (2019-06-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
di: M. A. Maksimova, et al.
Pubblicazione: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
di: M. A. Maksimova, et al.
Pubblicazione: (2015-09-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
di: Huijin Lee, et al.
Pubblicazione: (2024-10-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
di: Volpe M, et al.
Pubblicazione: (2012-06-01)

Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial)
di: Kenichiro Kinouchi, et al.
Pubblicazione: (2011-01-01)

Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
di: Han Saem Jeong, et al.
Pubblicazione: (2021-01-01)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
di: Youzheng Dong, et al.
Pubblicazione: (2022-09-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
di: Kenji Yamamoto, et al.
Pubblicazione: (2023-04-01)